Early Everolimus‐Facilitated Reduced Tacrolimus in Liver Transplantation: Results From the Randomized HEPHAISTOS Trial

Everolimus‐facilitated reduced‐exposure tacrolimus (EVR + rTAC) at 30 days after liver transplantation (LT) has shown advantages in renal preservation. This study evaluated the effects of early initiation of EVR + rTAC in de novo LT recipients (LTRs). In HEPHAISTOS (NCT01551212, EudraCT 2011‐003118‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Nashan, Björn, Schemmer, Peter, Braun, Felix, Schlitt, Hans J., Pascher, Andreas, Klein, Christian G., Neumann, Ulf P., Kroeger, Irena, Wimmer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291476/
https://www.ncbi.nlm.nih.gov/pubmed/34525259
http://dx.doi.org/10.1002/lt.26298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291476/
https://www.ncbi.nlm.nih.gov/pubmed/34525259
http://dx.doi.org/10.1002/lt.26298

Ejemplares similares